In the era of big data, the establishment of a free database, containing all the immune drug targets and associated cell types, is of great value. To this aim, the Guide to Immunopharmacology has been created in a joint effort between the International Union of Basic and Clinical Pharmacology (IUPHAR) and the International Union of Immunological Societies (IUIS). Here we highlight the structure and content of the database, which includes up-to-date quantitative information on the fundamental science underlying each immune target. A set of practical examples and tools for data mining are summarized to support immune research into drug discovery and therapeutics.
Guide to Immunopharmacology: a database to boost immunology education, research and therapy / Milling, S.; Spedding, M.; Maffia, P.. - In: IMMUNOLOGY. - ISSN 0019-2805. - 160:1(2020), pp. 1-2. [10.1111/imm.13201]
Guide to Immunopharmacology: a database to boost immunology education, research and therapy
Maffia P.
Ultimo
Project Administration
2020
Abstract
In the era of big data, the establishment of a free database, containing all the immune drug targets and associated cell types, is of great value. To this aim, the Guide to Immunopharmacology has been created in a joint effort between the International Union of Basic and Clinical Pharmacology (IUPHAR) and the International Union of Immunological Societies (IUIS). Here we highlight the structure and content of the database, which includes up-to-date quantitative information on the fundamental science underlying each immune target. A set of practical examples and tools for data mining are summarized to support immune research into drug discovery and therapeutics.File | Dimensione | Formato | |
---|---|---|---|
Immunology 2020 (Editorial).pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Accesso privato/ristretto
Dimensione
54.45 kB
Formato
Adobe PDF
|
54.45 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.